Accuracy of Robotically Assisted Cranial Biopsies
- Conditions
- Intracranial Neoplasm
- Interventions
- Device: Cirq® Robotic Alignment Module Cranial
- Registration Number
- NCT05891002
- Lead Sponsor
- Brainlab AG
- Brief Summary
This is an observational post-market study determining biopsy accuracy in a clinical environment using Cirq® Robotic Alignment Module Cranial. The goal is to determine whether the robotic procedure to be examined can achieve a clinically acceptable value of at least 90% in terms of diagnostic yield.
- Detailed Description
The goals of the project are to determine the accuracy of Cirq® Robotic Alignment Module Cranial navigated biopsy procedures, Automatic Image Registration accuracy within the workflow, and compatibility of Cirq® Robotic Alignment Module Cranial in the clinical workflow. Patients will undergo cranial biopsies according to standard of care using released products within their intended use with the exception that the accuracy of the biopsy needle will be measured using a specific intraoperative workflow.
Recruitment & Eligibility
- Status
- RECRUITING
- Sex
- All
- Target Recruitment
- 50
- Intracranial lesion and the indication for a diagnostic stereotactic biopsy validated by the neurosurgical staff
- Ability to consent to the procedure
- Pregnancy
- Contraindications on narcosis, operation, CT scan, MRI scan and/or Gadolinium contrast agent
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description Biopsy Patient Cirq® Robotic Alignment Module Cranial Patient with a confirmed intracranial neoplasm scheduled for a biopsy with Cirq® Robotic Alignment Module Cranial and registration via Auto-Registration Software Universal Automatic Image Registration Cranial and Loop-X® Mobile Imaging Robot.
- Primary Outcome Measures
Name Time Method Diagnostic yield 24 months Determine the percentage of diagnostically significant biopsies determined histologically
- Secondary Outcome Measures
Name Time Method Time for procedure 24 months Determine the time needed for the intraoperative biopsy procedure
Target point and entry point error 24 months Determine accuracy of biopsy needle by comparing the target and entry point location to the planned location
Trial Locations
- Locations (1)
The Centre Hospitalier Universitaire (CHU) d'Angers health establishment
🇫🇷Angers, France